Lista de obras - Allan Lawrie - Dominio Público Uruguay

A report on the use of animal models and phenotyping methods in pulmonary hypertension research

artículo científico

A therapeutic antibody targeting osteoprotegerin attenuates severe experimental pulmonary arterial hypertension

artículo científico publicado en 2019

A toolbox for the longitudinal assessment of healthspan in aging mice

artículo científico publicado en 2020

Apolipoprotein D and platelet-derived growth factor-BB synergism mediates vascular smooth muscle cell migration

artículo científico publicado en 2004

Apolipoprotein D inhibits platelet-derived growth factor-BB-induced vascular smooth muscle cell proliferated by preventing translocation of phosphorylated extracellular signal regulated kinase 1/2 to the nucleus

artículo científico publicado en 2003

Blood flow suppresses vascular Notch signalling via dll4 and is required for angiogenesis in response to hypoxic signalling.

artículo científico publicado en 2013

Bosutinib therapy resulting in severe deterioration of pre-existing pulmonary arterial hypertension.

artículo científico publicado en 2016

Deficiency of tumour necrosis factor-related apoptosis-inducing ligand exacerbates lung injury and fibrosis.

artículo científico publicado en 2012

Deprivation and prognosis in patients with Pulmonary Arterial Hypertension: missing the effect of deprivation on a rare disease?

artículo científico publicado en 2020

Differential IL-1 signaling induced by BMPR2 deficiency drives pulmonary vascular remodeling

artículo científico publicado en 2017

Elevated plasma CXCL12α is associated with a poorer prognosis in pulmonary arterial hypertension

artículo científico publicado en 2015

Expression Quantitative Trait Locus Mapping in Pulmonary Arterial Hypertension

artículo científico publicado en 2020

From bones to blood pressure, developing novel biologic approaches targeting the osteoprotegein pathway for pulmonary vascular disease

artículo científico publicado en 2016

Heart rate reduction with ivabradine promotes shear stress-dependent anti-inflammatory mechanisms in arteries

scientific article published on 14 April 2016

Identification of rare sequence variation underlying heritable pulmonary arterial hypertension

artículo científico publicado en 2018

Identifying early pulmonary arterial hypertension biomarkers in systemic sclerosis: Machine learning on proteomics from the DETECT cohort

artículo científico publicado en 2020

Influence of pre-analytical and analytical factors on osteoprotegerin measurements

artículo científico publicado en 2014

Inhibition of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) reverses experimental pulmonary hypertension

artículo científico publicado en 2012

Interdependent serotonin transporter and receptor pathways regulate S100A4/Mts1, a gene associated with pulmonary vascular disease

artículo científico publicado en 2005

Low-Dose FK506 (Tacrolimus) in End-Stage Pulmonary Arterial Hypertension

artículo científico publicado en 2015

MicroRNA in pulmonary vascular disease.

artículo científico

MicroRNA-140-5p and SMURF1 regulate pulmonary arterial hypertension

artículo científico publicado en 2016

Mts1/S100A4 stimulates human pulmonary artery smooth muscle cell migration through multiple signaling pathways

artículo científico publicado en 2005

No evidence for cardiac dysfunction in Kif6 mutant mice

artículo científico publicado en 2013

Osteoprotegerin in Cardiometabolic Disorders

artículo científico publicado en 2015

Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial Hypertension.

artículo científico publicado en 2016

Pulmonary Artery Denervation Attenuates Pulmonary Arterial Remodeling in Dogs With Pulmonary Arterial Hypertension Induced by Dehydrogenized Monocrotaline

artículo científico publicado en 2015

Pulmonary artery denervation reduces pulmonary artery pressure and induces histological changes in an acute porcine model of pulmonary hypertension

artículo científico publicado en 2015

Pulmonary hypertension in COPD: results from the ASPIRE registry.

artículo científico publicado en 2012

Reduced microRNA-150 is associated with poor survival in pulmonary arterial hypertension.

artículo científico publicado en 2012

S100A4 and bone morphogenetic protein-2 codependently induce vascular smooth muscle cell migration via phospho-extracellular signal-regulated kinase and chloride intracellular channel 4

artículo científico publicado en 2009

Selective improvement of pulmonary arterial hypertension with a dual ETA/ETB receptors antagonist in the apolipoprotein E-/- model of PAH and atherosclerosis.

artículo científico publicado en 2017

Serum osteoprotegerin is increased and predicts survival in idiopathic pulmonary arterial hypertension

artículo científico publicado en 2012

Targeting Vascular Remodeling to Treat Pulmonary Arterial Hypertension

artículo científico publicado en 2016

The Hepcidin/Ferroportin axis modulates proliferation of pulmonary artery smooth muscle cells

artículo científico publicado en 2018

The role of chemokines and chemokine receptors in pulmonary arterial hypertension

scientific article published on 10 August 2019

The role of the osteoprotegerin/tumor necrosis factor related apoptosis-inducing ligand axis in the pathogenesis of pulmonary arterial hypertension

artículo científico publicado en 2014

Ultrasound gene therapy: on the road from concept to reality.

artículo científico publicado en 2001

Ultrasound-enhanced transgene expression in vascular cells is not dependent upon cavitation-induced free radicals.

artículo científico publicado en 2003

Utilising artificial intelligence to determine patients at risk of a rare disease: idiopathic pulmonary arterial hypertension

artículo científico publicado en 2019

VP22-mediated intercellular transport correlates with enhanced biological activity of MybEngrailed but not (HSV-I) thymidine kinase fusion proteins in primary vascular cells following non-viral transfection

artículo científico publicado en 2005

miRNA-140-5p: new avenue for pulmonary arterial hypertension drug development?

artículo científico publicado en 2016

Lista de obras de Allan Lawrie

A report on the use of animal models and phenotyping methods in pulmonary hypertension research

A therapeutic antibody targeting osteoprotegerin attenuates severe experimental pulmonary arterial hypertension

A toolbox for the longitudinal assessment of healthspan in aging mice

Apolipoprotein D and platelet-derived growth factor-BB synergism mediates vascular smooth muscle cell migration

Apolipoprotein D inhibits platelet-derived growth factor-BB-induced vascular smooth muscle cell proliferated by preventing translocation of phosphorylated extracellular signal regulated kinase 1/2 to the nucleus

Blood flow suppresses vascular Notch signalling via dll4 and is required for angiogenesis in response to hypoxic signalling.

Bosutinib therapy resulting in severe deterioration of pre-existing pulmonary arterial hypertension.

Deficiency of tumour necrosis factor-related apoptosis-inducing ligand exacerbates lung injury and fibrosis.

Deprivation and prognosis in patients with Pulmonary Arterial Hypertension: missing the effect of deprivation on a rare disease?

Differential IL-1 signaling induced by BMPR2 deficiency drives pulmonary vascular remodeling

Elevated plasma CXCL12α is associated with a poorer prognosis in pulmonary arterial hypertension

Expression Quantitative Trait Locus Mapping in Pulmonary Arterial Hypertension

From bones to blood pressure, developing novel biologic approaches targeting the osteoprotegein pathway for pulmonary vascular disease

Heart rate reduction with ivabradine promotes shear stress-dependent anti-inflammatory mechanisms in arteries

Identification of rare sequence variation underlying heritable pulmonary arterial hypertension

Identifying early pulmonary arterial hypertension biomarkers in systemic sclerosis: Machine learning on proteomics from the DETECT cohort

Influence of pre-analytical and analytical factors on osteoprotegerin measurements

Inhibition of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) reverses experimental pulmonary hypertension

Interdependent serotonin transporter and receptor pathways regulate S100A4/Mts1, a gene associated with pulmonary vascular disease

Low-Dose FK506 (Tacrolimus) in End-Stage Pulmonary Arterial Hypertension

MicroRNA in pulmonary vascular disease.

MicroRNA-140-5p and SMURF1 regulate pulmonary arterial hypertension

Mts1/S100A4 stimulates human pulmonary artery smooth muscle cell migration through multiple signaling pathways

No evidence for cardiac dysfunction in Kif6 mutant mice

Osteoprotegerin in Cardiometabolic Disorders

Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial Hypertension.

Pulmonary Artery Denervation Attenuates Pulmonary Arterial Remodeling in Dogs With Pulmonary Arterial Hypertension Induced by Dehydrogenized Monocrotaline

Pulmonary artery denervation reduces pulmonary artery pressure and induces histological changes in an acute porcine model of pulmonary hypertension

Pulmonary hypertension in COPD: results from the ASPIRE registry.

Reduced microRNA-150 is associated with poor survival in pulmonary arterial hypertension.

S100A4 and bone morphogenetic protein-2 codependently induce vascular smooth muscle cell migration via phospho-extracellular signal-regulated kinase and chloride intracellular channel 4

Selective improvement of pulmonary arterial hypertension with a dual ETA/ETB receptors antagonist in the apolipoprotein E-/- model of PAH and atherosclerosis.

Serum osteoprotegerin is increased and predicts survival in idiopathic pulmonary arterial hypertension

Targeting Vascular Remodeling to Treat Pulmonary Arterial Hypertension

The Hepcidin/Ferroportin axis modulates proliferation of pulmonary artery smooth muscle cells

The role of chemokines and chemokine receptors in pulmonary arterial hypertension

The role of the osteoprotegerin/tumor necrosis factor related apoptosis-inducing ligand axis in the pathogenesis of pulmonary arterial hypertension

Ultrasound gene therapy: on the road from concept to reality.

Ultrasound-enhanced transgene expression in vascular cells is not dependent upon cavitation-induced free radicals.

Utilising artificial intelligence to determine patients at risk of a rare disease: idiopathic pulmonary arterial hypertension

VP22-mediated intercellular transport correlates with enhanced biological activity of MybEngrailed but not (HSV-I) thymidine kinase fusion proteins in primary vascular cells following non-viral transfection

miRNA-140-5p: new avenue for pulmonary arterial hypertension drug development?